Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Caribou Biosciences (CRBU) Receivables - Other (2020 - 2025)

Caribou Biosciences has reported Receivables - Other over the past 6 years, most recently at $1.9 million for Q4 2025.

  • Quarterly Receivables - Other rose 64.42% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 64.42% year-over-year, with the annual reading at $1.9 million for FY2025, 64.42% up from the prior year.
  • Receivables - Other was $1.9 million for Q4 2025 at Caribou Biosciences, up from $860000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $5.5 million in Q4 2021 and troughed at $830000.0 in Q2 2021.
  • The 5-year median for Receivables - Other is $1.9 million (2025), against an average of $2.3 million.
  • Year-over-year, Receivables - Other soared 312.88% in 2021 and then tumbled 59.94% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $5.5 million in 2021, then crashed by 59.02% to $2.2 million in 2022, then increased by 1.74% to $2.3 million in 2023, then plummeted by 49.34% to $1.2 million in 2024, then soared by 64.42% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Receivables - Other are $1.9 million (Q4 2025), $860000.0 (Q3 2025), and $2.0 million (Q2 2025).